The role of Six1 on miR‐155‐3p‐mediated TMZ resistance in glioma cells was assessed by cotransfecting human Six1 plasmids and mimics of miR‐155‐3p into A172 and U87 cells. This evidence concerns the gene SIX1 and central nervous system cancer.